Back to search
Mood Disorder
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Mood Disorder trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Mood Disorder trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This open-label functional Magnetic Resonance Imaging (fMRI) study will assess the effects of a single dose of psilocybin on rumination and the neural correlate…
Depression is a common condition, with serious negative effects on the health and quality of life of those affected. While there are currently various medicatio…
This study seeks to learn more about the symptoms of severe mood dysregulation in children and adolescents ages 7-17. Children and adolescents with severe mood…
This is a multicenter, global, 26-week, open-label study to assess the safety and tolerability of lumateperone in pediatric patients with schizophrenia, bipolar…
This is a quasi-experimental, multi-site cluster controlled clinical trial design with two intervention arms--Treatment As Usual (TAU) and an Integrated Care Pa…
The purpose of this study is to determine the efficacy, safety and tolerability of CYB003 compared to matching placebo as adjunctive treatment in patients with…
This trial aims to evaluate the effectiveness of a novel intervention for patients with co-occurring bipolar and substance use disorders following a psychiatric…
Background: Irritability is defined as proneness to anger that may impair a person's ability to function. It is a common reason for why some children need ment…